tenoxicam

Phase 2Small molecule

NNational Taiwan University Hospital

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Temporomandibular Joint Internal DerangementActive, not recruiting

Temporomandibular Joint Internal DerangementPhase 2

Active, not recruiting

Timeline

Expected Milestones

Q1 2027

ApprovedNot yet recruiting

Urolithiasis

NCT07512297

Clinical

Trials by Indication[1]

Osteoarthritis2 trials

Injection of Tenoxicam Versus Arthrocentesis Alone in the Treatment of Temporomandibular Joint Osteoarthritis

Completed·—·Phase 1·NCT05497570·30 enrolled

Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management

Completed·—·N/A·NCT07194135·100 enrolled

Analgesic Efficacy1 trial

Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam

Unknown status·TTC Erciyes University·Phase 4·NCT02160236·90 enrolled

Efficacy1 trial

Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam

Completed·UUniversity of Sao Paulo·Phase 4·NCT04182191·89 enrolled

Gastrointestinal Function1 trial

Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia

Unknown status·NNational Taiwan University Hospital·N/A·NCT04314310·30 enrolled

Migraine1 trial

Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack

Active, not recruiting·HHaydarpasa Numune Training and Research Hospital·Phase 4·NCT06786650·100 enrolled

5 more indications

Temporomandibular Joint Internal Derangement1 trial

Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement

Active, not recruiting·MMansoura University·Phase 1/2·NCT06572904·60 enrolled

Intravenous1 trial

Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain

Completed·OOrdu University·Phase 4·NCT02285972·118 enrolled

Analgesia1 trial

Tenoxicam for Intrapartum Analgesia

Unknown status·—·Phase 2·NCT02549118·100 enrolled

Urolithiasis1 trial

Comparative Evaluation of Non-Opioid Analgesics for Pain Control During Extracorporeal Shock Wave Lithotripsy: A Prospective Randomized Controlled Trial

Not yet recruiting·UUniversity of Gaziantep·Approved·NCT07512297·160 enrolled

Bruxism1 trial

Short-Term Patient-Reported Symptom Changes Across Clinically Selected Management Pathways in Adults With Bruxism-Related and Temporomandibular Disorder Symptoms: A Prospective Non-Randomized Observational Study

Completed·RRecep Tayyip Erdogan University··NCT07586072·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for tenoxicam. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — tenoxicam compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for tenoxicam. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Taiwan University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNational Taiwan University Hospital